# Potential Involvement of PI3K/AKT Signaling Pathway in the Protective Effects of Rhinacanthus nasutus Against Diabetic Nephropathy-Induced Oxidative Stress

**Authors:** Junyu Liu, Yehao Lin, Xudong Yi, Min Zhang, Pharkphoom Panichayupakaranant, Joseph Buhagiar, Haixia Chen

PMC · DOI: 10.3390/antiox15020252 · Antioxidants · 2026-02-14

## TL;DR

This study shows that Rhinacanthus nasutus extract may protect against diabetic kidney damage by reducing oxidative stress and regulating glucose uptake.

## Contribution

The novel contribution is identifying Rhinacanthus nasutus as a potential natural treatment for diabetic nephropathy via the PI3K/AKT pathway.

## Key findings

- Rhinacanthus nasutus extract reduced oxidative stress markers in diabetic rats.
- The extract upregulated PI3K/AKT signaling and improved glucose uptake in cell assays.
- Bioavailable compounds like caffeic acid and naringenin were identified as key constituents.

## Abstract

Oxidative stress is a primary driver of diabetic nephropathy (DN), highlighting the urgent need for potent natural antioxidants. This study explored the reno-protective potential and associated mechanisms of Rhinacanthus nasutus aqueous extract (AE). Phytochemical profiling via Q Exactive HF Orbitrap LC–MS/MS and serum pharmacochemistry analysis identified 38 constituents, among which 25 bioavailable constituents (e.g., caffeic acid and naringenin) might be the key bioactive ones. In the L6 myotubes in vitro assays, AE (75 μg/mL) was observed to upregulate the PI3K/AKT and GLUT4 signaling cytokines, coinciding with enhanced glucose uptake, as confirmed by Western blot with insulin as a positive control. Furthermore, in STZ-induced DN rats, AE could reduce MDA levels (0.58 vs. 1.44 nmol/mgprot) and restore T-SOD, CAT, and GSH-Px levels (170.57, 51.93, 63.68 vs. 114.93, 40.84, 50.99 mgprot). The protective effects were accompanied by the modulation of PI3K/AKT/mTOR signaling axis. These findings suggest that AE exerts dual efficacy involving glucose uptake regulation and oxidative stress inhibition. Consequently, Rhinacanthus nasutus represents a promising natural antioxidant resource with potential for the management of DN.

## Linked entities

- **Proteins:** PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), AKT1 (AKT serine/threonine kinase 1), SLC2A4 (solute carrier family 2 member 4), CAT (catalase), Gpx1 (glutathione peroxidase 1)
- **Chemicals:** caffeic acid (PubChem CID 689043), naringenin (PubChem CID 932), MDA (PubChem CID 1614)
- **Diseases:** diabetic nephropathy (MONDO:0005016)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Slc2a4 (solute carrier family 2 member 4) [NCBI Gene 25139] {aka Glut4}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Gpx1 (glutathione peroxidase 1) [NCBI Gene 24404] {aka GSHPx, GSHPx-1}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56718] {aka Frap1, RAFT1}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 25513] {aka PI3KA}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Slc2a4 (solute carrier family 2 (facilitated glucose transporter), member 4) [NCBI Gene 20528] {aka GT2, Glut-4, Glut4, twgy}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Pik3cb (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta) [NCBI Gene 85243], Src (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 83805], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Igf1 (insulin-like growth factor 1) [NCBI Gene 24482] {aka IGF}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Pik3ca (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) [NCBI Gene 170911], Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}
- **Diseases:** liver dysfunction (MESH:D017093), kidney destruction (MESH:D007674), necrosis (MESH:D009336), mesangial matrix hyperplasia (MESH:D006965), DN (MESH:D003928), diabetic complications (MESH:D048909), AEB (MESH:D006402), hypertension (MESH:D006973), reperfusion injury (MESH:D015427), Cytotoxicity (MESH:D064420), cough (MESH:D003371), end-stage renal disease (MESH:D007676), myocardial ischemia (MESH:D017202), renal hypertrophy (MESH:D006984), stroke (MESH:D020521), intestinal epithelial injury (MESH:C567703), vacuolar degeneration (MESH:C536522), proteinuria (MESH:D011507), metabolic dysfunction (MESH:D008659), hyperglycemia (MESH:D006943), fibrosis (MESH:D005355), inflammation (MESH:D007249), injury to (MESH:D014947), glucose metabolism disorders (MESH:D044882), tubular injury (MESH:D000230), Diabetes (MESH:D003920), renal failure (MESH:D051437), arteriosclerosis (MESH:D001161)
- **Chemicals:** sterols (MESH:D013261), Na2CO3 (MESH:C005686), Naringenin (MESH:C005273), sesquiterpenes (MESH:D012717), ABTS (MESH:C002502), lipid (MESH:D008055), polyphenol (MESH:D059808), ROS (MESH:D017382), Periodic acid (MESH:D010504), dihydroferulic acid (MESH:C520807), flavonoid (MESH:D005419), syringic acid (MESH:C001945), Glucose (MESH:D005947), Caffeic acid (MESH:C040048), PVDF (MESH:C024865), 3-methoxy phenylacetic acid (MESH:C023699), gentisic acid (MESH:C010925), H&amp;E (MESH:D006371), 2-NBDG (MESH:C098340), naphthoquinones (MESH:D009285), H2O2 (MESH:D006861), Acarbose (MESH:D020909), AE (-), MDA (MESH:D008315), triterpenes (MESH:D014315), isoflavones (MESH:D007529), MTT (MESH:C070243), terpenoids (MESH:D013729), coumarin (MESH:C030123), STZ (MESH:D013311), cinnamic acid (MESH:C029010), iron (MESH:D007501), phenolic acid (MESH:C017616), ferulic acid (MESH:C004999), Met (MESH:D008687), water (MESH:D014867), salvianolic acid B (MESH:C076944), CCK-8 (MESH:D012844), blood glucose (MESH:D001786), ascorbic acid (MESH:D001205), SDS (MESH:D012967), 2-hydroxybenzaldehyde (MESH:C013243), phosphate (MESH:D010710), methanol (MESH:D000432), p-nitrophenyl-alpha-D-glucopyranoside (MESH:C019502), DPPH (MESH:C004931), esters (MESH:D004952), nitrogen (MESH:D009584), MDA (MESH:D015104), hesperidin (MESH:D006569), EDTA (MESH:D004492)
- **Species:** Rhinacanthus nasutus (species) [taxon 537489], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Squalomugil nasutus (shark mullet, species) [taxon 1040953], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** L6 — Mus musculus (Mouse), Hybridoma (CVCL_XK50), IEC-6 — Rattus norvegicus (Rat), Finite cell line (CVCL_0343)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938351/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12938351/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938351/full.md

---
Source: https://tomesphere.com/paper/PMC12938351